Concepedia

Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products

Bo Feng, Lei Xu, Hua Wang, Xinfeng Yan, Junli Xue, Fengjing Liu, Ji‐Fan Hu

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2011 · 40 citations · 44 references

DOIFull text

Open access

Concepts

References

44

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

The Lancet · 2002 · 7K citations

, , +13

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Helen M. Colhoun, D. J. Betteridge, Paul N. Durrington et al. · The Lancet · 2004 · 3.8K citations

, , +9

The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin

Osamu Hori, J Brett, Timothy Slattery et al. · Journal of Biological Chemistry · 1995 · 1.1K citations · Full text

, , +7

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE

Marie‐Paule Wautier, Olivier Chappey, Stefano Corda et al. · American Journal of Physiology-Endocrinology and Metabolism · 2001 · 1.1K citations

, , +17

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

Ann Marie Schmidt, Shi Du Yan, Shi Fang Yan et al. · Journal of Clinical Investigation · 2001 · 1K citations · Full text

, , +17